Clinical Trial Update: A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212 [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the effect of trametinib (GSK1120212) on cardiac electrical activity in patients with solid tumors, assessed before and after treatme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• GSK1120212 (trametinib) (trametinib)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Cancer | Phase 1 | Status: COMPLETED